Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis

被引:109
|
作者
Zhu, Jie [1 ]
Shi, Huirong [1 ]
Liu, Huina [1 ]
Wang, Xiaojuan [1 ]
Li, Fengmei [2 ]
机构
[1] Zhengzhou Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Cent Hosp, Dept Obstet & Gynecol, Zhengzhou 450000, Henan, Peoples R China
关键词
cervical cancer; TUG1; SIRT1; miR-138-5p; Wnt/beta-catenin; COMPETING ENDOGENOUS RNA; POOR-PROGNOSIS; INCREASES CHEMORESISTANCE; COLORECTAL-CANCER; CELL; ACTIVATION; APOPTOSIS; GLIOMA;
D O I
10.18632/oncotarget.18224
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increasing evidences showed that long non-coding RNAs (lncRNAs) play vital roles in tumor progression. Recent studies indicated that lncRNA TUG1 was upregulated and promoted tumor processes in several cancers. However, the expression and underlying mechanism of TUG1 in cervical cancer remain unclear. In the present study, we found that TUG1 expression was upregulated in cervical cancer tissues and correlated with advanced clinical features and poor overall survival. TUG1 knockdown suppressed cervical cancer cell growth and metastasis in vitro and tumor growth in vivo. In addition, our results indicated that TUG1 could act as an endogenous sponge by directly binding to miR-138-5p and suppressed miR-138-5p expression. Furthermore, we found that TUG1 could reverse the inhibitory effect of miR-138-5p on cervical cancer cells processes, which might be involved in the activation of SIRT1, a target gene of miR-138-5p, and activation of Wnt/beta-catenin signaling pathway. Taken together, we elucidated that TUG1 might promote cervical cancer malignant progression via miR-138-5p-SIRT1-Wnt/beta-catenin signaling pathway axis.
引用
收藏
页码:65253 / 65264
页数:12
相关论文
共 50 条
  • [21] Long Noncoding RNA NEAT1 Promotes the Progression of Breast Cancer by Regulating miR-138-5p/ZFX Axis
    Yao, Lige
    Chen, Lu
    Zhou, Hanli
    Duan, Fangfang
    Wang, Liuyan
    Zhang, Yujie
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (08) : 636 - 649
  • [22] Long non-coding RNA TUG1 promotes proliferation and migration in PDGF-BB-stimulated HASMCs by regulating miR-216a-3p/SMURF2 axis
    Wang, Xinfang
    Chen, Junsong
    BMC MOLECULAR AND CELL BIOLOGY, 2021, 22 (01)
  • [23] Long non-coding RNA 00152 promotes cell proliferation in cervical cancer via regulating miR-216b-5p/HOXA1 axis
    Zheng, J-J
    Du, X-J
    Wang, H-P
    Zhou, L-Y
    Wang, Y-J
    Zhang, L.
    Xu, H.
    Zhang, J.
    Hu, Z-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (09) : 3654 - 3663
  • [24] Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis
    Huang, Xing
    Wang, Zihe
    Hou, Shengzhong
    Yue, Chao
    Li, ZhenLu
    Hu, Weiming
    Lu, Huimin
    BIOENGINEERED, 2022, 13 (02) : 4153 - 4165
  • [25] Inhibition of long non-coding RNA TUG1 protects against diabetic cardiomyopathy induced diastolic dysfunction by regulating miR-499-5p
    Zhao, Lei
    Li, Weiguo
    Zhao, Hao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (03): : 718 - 730
  • [26] Long non-coding RNA TUG1 promotes proliferation and migration in PDGF-BB-stimulated HASMCs by regulating miR-216a-3p/SMURF2 axis
    Xinfang Wang
    Junsong Chen
    BMC Molecular and Cell Biology, 22
  • [27] Tumorigenic role of non-coding RNA, TUG1 in pancreatic cancer
    Tasaki, Yoshihiko
    Katsushima, Keisuke
    Shinjo, Keiko
    Suzuki, Miho
    Totani, Haruhito
    Mase, Shoko
    Murashima, Akihiro
    Miyata, Kanjiro
    Kataoka, Kazunori
    Kimura, Kazunori
    Kondo, Yutaka
    CANCER SCIENCE, 2018, 109 : 1250 - 1250
  • [29] Long Non-Coding RNA ZEB2-AS1 Promotes Hepatocellular Carcinoma Progression by Regulating The miR-582-5p/ FOXC1 Axis
    Wu, Shimin
    Chen, Juan
    Liang, Ying
    Luo, Qian
    Tong, Yaoyao
    Xie, Ling
    CELL JOURNAL, 2022, 24 (06) : 285 - 293
  • [30] LncRNA TUG1 contributes to the tumorigenesis of lung adenocarcinoma by regulating miR-138-5p-HIF1A axis
    Li, Ke
    Niu, Huatao
    Wang, Ying
    Li, Ruilei
    Zhao, Yuan
    Liu, Chao
    Cao, Honghua
    Chen, Haitao
    Xie, Ran
    Zhuang, Li
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2021, 35